Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 16.07B | $ 13.14B | $ 13.85B | $ 6.12B | $ 10.31B |
Total Assets | $ 62.34B | $ 71.32B | $ 70.81B | $ 53.82B | $ 45.66B |
Total Debt | $ 15.61B | $ 16.15B | $ 10.89B | $ 8.27B | $ 5.98B |
Net Debt | $ -460.00M | $ 3.01B | $ -2.96B | $ 2.15B | $ -4.33B |
Total Liabilities | $ 21.58B | $ 21.19B | $ 16.42B | $ 12.96B | $ 9.14B |
Stockholders Equity | $ 16.94B | $ 20.58B | $ 21.86B | $ 29.19B | $ 26.44B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |